OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 155 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2015$784,000,000
-35.6%
50,000
-37.5%
0.02%
-19.0%
Q4 2014$1,217,000,000
-6.0%
80,000
-33.3%
0.02%
-4.5%
Q3 2014$1,294,000,000
-15.3%
120,000
+20.0%
0.02%
-26.7%
Q2 2014$1,527,000,000
-63.3%
100,000
-56.5%
0.03%
-62.0%
Q1 2014$4,158,000,000
+368.2%
230,000
+259.6%
0.08%
+393.8%
Q4 2013$888,000,000
-62.3%
63,959
-71.6%
0.02%
-67.3%
Q3 2013$2,358,000,000225,0000.05%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders